Gilron | Anesthesiology and Perioperative Medicine | School of Medicine

Dr. Ian Gilron MD, MSc, FRCPC

Position(s)

Professor

Biomedical & Molecular Sciences; Centre for Neuroscience Studies; School of Policy Studies

Director of Clinical Pain Research

Chair of Reappointment, Continuing and Promotions Committee

Chair of Research Committee

Ian Gilron is an Anesthesiologist and Pain Physician, Professor of Anesthesiology, Biomedical Sciences, Neuroscience, and Policy Studies, and Director of Clinical Pain Research at Queen’s University in Kingston, Ontario, Canada. Dr. Gilron conducts research on mechanisms and treatment of pain and is interested in health and science policy related to pain management and analgesic use. He serves as Principal Investigator on several research programs with continuous peer-reviewed funding since 2000. Among over 220 career-spanning peer-reviewed publications, work from Dr. Gilron’s team at Queen’s University has been published in the New England Journal of Medicine, Lancet, CMAJ, Pain, Anesthesiology and other journals. He has co-authored the 2025 IASP NeuPSIG guidelines on neuropathic pain treatment as well as several other consensus statements regarding pain treatment and research. Dr. Gilron has served on the Council and other Committees at IASP and is currently a Clinical Sciences Section Editor for the IASP journal PAIN.

Selected publications:

Navarro R, Hopman W, Gilron I. Pain chronobiology in clinical trial participants with fibromyalgia: a comparison with neuropathic pain. Pain Rep 2025;10:e1307.
Gilron I, Elkerdawy H, Tu D, Holden RR, Moulin DE, Duggan S, Milev R. Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trial. Pain 2025;166:2541.
Gilron I, Xiao MZX, Carley M, Salter MW, Hutchinson MR, Moulin DE, Moore RA, Ross-White A. Glial-modulating agents for the treatment of pain: a systematic review. Pain 2025;166:1030.
Gilron I, Lao N, Carley M, Camiré D, Kehlet H, Brennan TJ, Erb J. Movement-evoked Pain versus Pain at Rest in Postsurgical Clinical Trials and in Meta-analyses: An Updated Systematic Review. Anesthesiology. 2024;140:442.
Gilron I, Robb S, Tu D, Holden RR, Jackson AC, Duggan S, Milev R. Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trial. Pain 2024;165:461.
Park R, Mohiuddin M, Arellano R, Pogatzki-Zahn E, Klar G, Gilron I. Prevalence of postoperative pain after hospital discharge: systematic review and meta-analysis. Pain Rep 2023;8:e1075.
Balanaser M, Carley M, Baron R, Finnerup NB, Moore RA, Rowbotham MC, Chaparro LE, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis. Pain 2023;164:230.
Sohi G, Lao N, Caraceni A, Moulin DE, Zimmermann C, Herx L, Gilron I. Nonopioid drug combinations for cancer pain: a systematic review. Pain Rep 2021;7:e995.
Carley ME, Chaparro LE, Choinière M, Kehlet H, Moore RA, Van Den Kerkhof E, Gilron I. Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis. Anesthesiology 2021;135:304.
Gilron I, Carr DB, Desjardins PJ, Kehlet H. Current methods and challenges for acute pain clinical trials. Pain Rep 2018;4:e647.
Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. 2018 Feb 19;2:CD010585.
Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment.Mayo Clin Proc 2015;90:532.
Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol 2013;12:1084.
Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain. Lancet 2009;374:1252.
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324.

Team

Faculty